Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
| Autor: | Pautier, Patricia a, ⁎, Joly, Florence b, Kerbrat, Pierre c, Bougnoux, Philippe d, Fumoleau, Pierre e, Petit, Thierry f, Rixe, Olivier g, Ringeisen, François h, Carrasco, Annie Tisseron i, Lhommé, Catherine a |
|---|---|
| Zdroj: | In Gynecologic Oncology 2010 116(2):157-162 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect